Results 211 to 218 of about 372,299 (218)

Serum 25-Hydroxyvitamin D Levels and Risk of Multiple Sclerosis

JAMA - Journal of the American Medical Association, 2006
Kassandra L Munger, Alberto Ascherio, Bruce Hollis   +2 more
exaly  

Premyelinating Oligodendrocytes in Chronic Lesions of Multiple Sclerosis

New England Journal of Medicine, 2002
Bruce D Trapp, Richard A. Rudick, Ansi Chang   +2 more
exaly  

Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis after a First Demyelinating Event

New England Journal of Medicine, 2003
Hanno Ulmer, Markus Reindl
exaly  

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

New England Journal of Medicine, 2012
Robert J. Fox, Vissia Viglietta, Michael Hutchinson   +2 more
exaly  

Multiple Sclerosis

New England Journal of Medicine, 1982
Henry F McFarland, Dale E McFarlin, D E McFarlin   +2 more
exaly  

Inflammatory Cortical Demyelination in Early Multiple Sclerosis

New England Journal of Medicine, 2011
Hans Lassmann, Joseph E Parisi, Wolfgang Brück   +2 more
exaly  

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

New England Journal of Medicine, 2017
Fred D. Lublin, Bernhard Hemmer, Amit Bar-or   +2 more
exaly  

Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

New England Journal of Medicine, 2012
Gavin Giovannoni, Krzysztof Selmaj, Ludwig Kappos   +2 more
exaly